Medpace(MEDP)
CINCINNATI, OHCRO (Contract Research)
Focus: Medpace is a publicly traded contract research organization (CRO) headquartered in Cincinnati with 5,001-10,000 employees, providing clinical trial and drug development services across diverse therapeutic areas.
Funding Stage
PUBLIC
Employees
5001-10000
Open Jobs
0
About Medpace
Not HiringNo open roles listed right now. Follow Medpace to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
- Strong financial trajectory with $1.9B FY2025 revenue (+27% YoY) and $283M net income demonstrates business stability and growth
- Exposure to 100+ pipeline programs across oncology, cardiovascular, infectious disease, and rare disease creates diverse learning opportunities
- Public company status with profitable operations ($283M net income) provides job security and career predictability
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$1.9B
Pipeline & Clinical Trials
18F Fluoroestradiol Radiopharmaceutical with PET/CT
Metastatic Breast CancerCrossing of Coronary Artery CTO
Coronary Artery DiseaseClinical Trials (1)
Help build intelligence for Medpace
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.